Cognition in school-age children exposed to levetiracetam, topiramate, or sodium valproate

Neurology

Volumn 87, Issue 18, 2016, Pages 1943-1953

  Bromley, Rebecca L ^a,d   Calderbank, Rebecca ^a,e   Cheyne, Christopher P ^f   Rooney, Claire ^h   Trayner, Penny ^b   Clayton Smith, Jill ^g,i   García Fiñana, Marta ^f   Irwin, Beth ^j   Morrow, James Irvine ^j   Shallcross, Rebekah ^c   Baker, Gus A ^g  

^a Institute of Human Development   (United Kingdom)

^b Department of Clinical Psychology ^*  (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^e LANCASTER UNIVERSITY   (United Kingdom)

^f Departments of Biostatistics   (United Kingdom)

^g UNIVERSITY OF LIVERPOOL   (United Kingdom)

^h MERSEY CARE NHS TRUST   (United Kingdom)

ⁱ ST MARY S HOSPITAL   (United Kingdom)

^j ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; LEVETIRACETAM; TOPIRAMATE; VALPROIC ACID; ANTICONVULSIVE AGENT; ETIRACETAM; FRUCTOSE; PIRACETAM;

ADVERSE OUTCOME; ARTICLE; CHILD; COGNITION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG DOSE INCREASE; DRUG EXPOSURE; EXECUTIVE FUNCTION; FEMALE; HUMAN; INTELLIGENCE QUOTIENT; LANGUAGE ABILITY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NONVERBAL COMMUNICATION; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PRENATAL EXPOSURE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SOCIAL STATUS; VERBAL COMMUNICATION; ADULT; ANALOGS AND DERIVATIVES; CHEMICALLY INDUCED; COGNITIVE DEFECT; EPILEPSY; FOLLOW UP; PATHOPHYSIOLOGY; PREGNANCY; YOUNG ADULT;

ADULT; ANTICONVULSANTS; CHILD; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; FRUCTOSE; HUMANS; MALE; PIRACETAM; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; VALPROIC ACID; YOUNG ADULT;

EID: 84994087101     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000003157     Document Type: Article

References (31)

1. Ackers R, Besag FM, Wade A, Murray ML, Wong IC. Changing trends in antiepileptic drug prescribing in girls of child-bearing potential. Arch Dis Child 2009; 94:443-447.
2. Hernandez-Diaz S, Smith CR, Shen A, et al. Comparative safety of antiepileptic drugs during pregnancy. Neurology 2012;78:1692-1699.
3. Wen X, Meador KJ, Hartzema A. Antiepileptic drug use by pregnant women enrolled in Florida Medicaid. Neurology 2015;84:944-950.
4. Meador KJ, Baker GA, Browning N, et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 2009;360:1597-1605.
5. Bromley RL, Mawer G, Love J, et al. Early cognitive development in children born to women with epilepsy: a prospective report. Epilepsia 2010;51:2058-2065.
6. Meador KJ, Baker GA, Browning N, et al. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD Study): a prospective observational study. Lancet Neurol 2013;12:244-252.
7. Baker GA, Bromley RL, Briggs M, et al. IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study. Neurology 2015;84:382-390.
8. Bromley R, Weston J, Adab N, et al. Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child. Cochrane Database Syst Rev 2014:CD010236.
9. Shallcross R, Bromley RL, Cheyne CP, et al. In utero exposure to levetiracetam vs valproate: development and language at 3 years of age. Neurology 2014;82: 213-221.
10. Shallcross R, Bromley RL, Irwin B, et al. Child development following in utero exposure: levetiracetam vs sodium valproate. Neurology 2011;76:383-389.
11. Rihtman T, Parush S, Ornoy A. Preliminary findings of the developmental effects of in utero exposure to topiramate. Reprod Toxicol 2012;34:308-311.
12. Morrow J, Russell A, Guthrie E, et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006;77:193-198.
13. Brown L, Sherbenou RJ, Johnsen SK. Test of Non-Verbal Intelligence (TONI-3), 3rd ed. Austin: PRO-ED; 1997.
14. Wechsler D. Wechsler Intelligence Scale for Children-Fourth UK Edition. San Antonio: The Psychological Corporation; 2004.
15. Wechsler D. Pre-school and Primary Scale of Intelligence-Third UK Edition. San Antonio: The Psychological Corporation; 2003.
16. Korkman M, Kemp S, Kirk U. NEPSY-II Clinical and Interpretive Manual. San Antonio: The Psychological Corporation; 2007.
17. Semel E, Wiig E, Secord W. Clinical Evaluation of Language Fundamentals, 4th ed. London: Harcourt Publishers; 2006.
18. Reynolds CR, Kamphaus RW. Behaviour Assessment System for Children, 2nd ed. San Antonio: Pearson; 2004.
19. Molenberghs G, Kenwood M. Missing Data in Clinical Studies. New York: Wiley; 2007.
20. Faul F, Erdfelder E, Lang A, Buchner A. GPower: a flexible statistical power analysis for the social, behavioural, and biomedical sciences. Behav Res Methods 2007;39:175-191.
21. Kim J, Kondratyev A, Gale K. Antiepileptic druginduced neuronal cell death in the immature brain: effects of carbamazepine, topiramate and levetiracetam as monotherapy versus polytherapy. Pharmacol Exp Ther 2007;323:165-173.
22. Craig JJ, Hunt SJ. Treating women with juvenile myoclonic epilepsy. Pract Neurol 2009;9:268-277.
23. Mawhinney E, Craig J, Morrow J, et al. Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers. Neurology 2013;80:400-405.
24. Alsaad AM, Chaudhry SA, Koren G. First trimester exposure to topiramate and the risk of oral clefts in the offspring: a systematic review and meta-analysis. Reprod Toxicol 2015;53:45-50.
25. Glier C, Dzietko M, Bittigau P, Jarosz B, Korobowicz E, Ikonomidou C. Therapeutic doses of topiramate are not toxic to the developing rat brain. Exp Neurol 2004;187: 403-409.
26. Adab N, Kini U, Vinten J, et al. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2004;75:1575-1583.
27. Nadebaum C, Anderson V, Vajda F, Reutens D, Barton S, Wood A. The Australian Brain and Cognitive and Antiepileptic Drugs Study: IQ in school-aged children exposed to sodium valproate and polytherapy. J Int Neuropsychol Soc 2011;17:133-142.
28. Cummings C, Stewart M, Stevenson M, Morrow J, Nelson J. Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine. Arch Dis Child 2011;96:643-647.
29. Gaily E, Kantola-Sorsa E, Hiilesmaa V, et al. Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 2004;62:28-32.
30. Deary IJ, Strand S, Smith P, Fernandes C. Intelligence and educational achievement. Intelligence 2007;35:13-21.
31. Brent RL. Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors. Pediatrics 2004;113(4 suppl):957-968.